Avoided cost in chemotherapy drugs by patient inclusion in clinical trials.
03 medical and health sciences
0302 clinical medicine
3. Good health
DOI:
10.1200/jco.2014.32.15_suppl.e17544
Publication Date:
2019-01-03T22:34:11Z
AUTHORS (13)
ABSTRACT
e17544 Background: To determine the direct economic impact attributable to drugs assigned to patients (pts) enrolled in clinical trials (CT) by the medical oncology department of a third level hosp...
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....